NCT02014181View on ClinicalTrials.gov

Flaxseed Modulates Inflammation and Oxidative Stress in CF

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions
Cystic FibrosisOxidative StressInflammation
Interventions
DIETARY_SUPPLEMENT

finely ground flaxseed powder

40 grams finely ground flaxseed powder daily for one month to patients with cystic fibrosis

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT02014181 - Flaxseed Modulates Inflammation and Oxidative Stress in CF | Biotech Hunter | Biotech Hunter